Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

123
Body:Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
123
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

502
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
502
Crossover Experiments01:16

Crossover Experiments

4.4K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
4.4K
Clinical Trials01:16

Clinical Trials

10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.1K
Bioequivalence Data: Statistical Interpretation01:16

Bioequivalence Data: Statistical Interpretation

148
Body:The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
148
Regression Toward the Mean01:52

Regression Toward the Mean

6.8K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Generalizing Treatment Effect to a Target Population Without Individual Patient Data in a Real-World Setting.

Pharmaceutical statistics·2024
Same author

Patient journey through cases of depression from claims database using machine learning algorithms.

PloS one·2021
Same author

A retrospective analysis to estimate the healthcare resource utilization and cost associated with treatment-resistant depression in commercially insured US patients.

PloS one·2020
Same author

Designing A Pathogen-Focused Study To Address The High Unmet Medical Need Represented By Carbapenem-Resistant Gram-Negative Pathogens - The International, Multicenter, Randomized, Open-Label, Phase 3 CREDIBLE-CR Study.

Infection and drug resistance·2019
Same author

Defining Regions in Multiregional Clinical Trials: An Analytical Approach to Considering Impact of Intrinsic and Extrinsic Factors.

Therapeutic innovation & regulatory science·2018
Same author

Assessing Treatment Effects That Capture Disease Burden in Serious Chronic Diseases.

Therapeutic innovation & regulatory science·2018

Related Experiment Video

Updated: Dec 29, 2025

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.1K

Lessons Learned From Multi-regional Trials With Signals of Treatment Effect Heterogeneity.

Gang Li1, Hui Quan2, Gordon Lan3

  • 1Janssen R&D US, 920 US Highway 202 S, Raritan, NJ, 08869, USA. ligang8844@gmail.com.

Therapeutic Innovation & Regulatory Science
|February 3, 2020
PubMed
Summary

To improve the accuracy of multi-regional clinical trial (MRCT) results, minimize regional inconsistency by carefully planning protocols and monitoring early data. This ensures reliable interpretation of treatment effects, especially for life-threatening conditions.

Keywords:
MRCTdrop-mininconsistencysubgroup analysis

More Related Videos

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups
14:14

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups

Published on: May 13, 2022

6.2K
Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
07:54

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

19.1K

Related Experiment Videos

Last Updated: Dec 29, 2025

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.1K
The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups
14:14

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups

Published on: May 13, 2022

6.2K
Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
07:54

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

19.1K

Area of Science:

  • Clinical Trials
  • Health Services Research
  • Biostatistics

Background:

  • Multi-regional clinical trials (MRCTs) are increasingly common but face challenges with inconsistent results across different regions.
  • Heterogeneity in treatment effects across regions can complicate trial interpretation and impact regulatory decisions.

Purpose of the Study:

  • To review studies with inconsistent treatment effects and identify lessons learned.
  • To provide recommendations for minimizing inconsistency and improving the interpretation of MRCT results.

Main Methods:

  • Systematic review of published studies reporting inconsistent treatment effects in MRCTs.
  • Analysis of common factors contributing to regional heterogeneity.
  • Development of strategies to address potential sources of inconsistency.

Main Results:

  • Key recommendations include minimizing regions for consistency evaluation to avoid false signals.
  • Proactively addressing regional differences in culture and medical practices within the protocol is crucial.
  • Close monitoring of early blinded data can identify imbalances and outcome rate inconsistencies.

Conclusions:

  • Implementing these strategies can minimize false inconsistency signals and improve the accuracy of MRCT interpretation.
  • Careful consideration of decision criteria is essential, particularly for trials involving life-threatening conditions where accurate results are critical.